These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30466840)

  • 1. Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2018 Dec; 48(12):321-332. PubMed ID: 30466840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M; Liblanc M
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Latest in Teen Pregnancy Prevention: Long-Acting Reversible Contraception.
    McClellan K; Temples H; Miller L
    J Pediatr Health Care; 2018; 32(5):e91-e97. PubMed ID: 30180941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol; 2018 May; 131(5):e130-e139. PubMed ID: 29683910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
    Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
    J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z; Biro FM; Kollar LM; Rauh JL
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent satisfaction with postpartum contraception and body weight concerns.
    Hellerstedt WL; Story M
    J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
    Dodson NA; Gray SH; Burke PJ
    Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
    Paul R; Huysman BC; Maddipati R; Madden T
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Satisfaction with and intention to continue Depo-Provera versus the Mirena IUD among post-partum adolescents through 12 months of follow-up.
    Howard DL; Wayman R; Strickland JL
    J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):358-65. PubMed ID: 24238267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
    Morgan IA; Zapata LB; Curtis KM; Whiteman MK
    J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Continuation of Long-Acting Reversible Contraception Among Adolescents Receiving Medicaid.
    Allison BA; Ritter V; Lin FC; Flower KB; Perry MF
    J Adolesc Health; 2024 Sep; 75(3):487-495. PubMed ID: 38980246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
    East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Acting Reversible Contraception for Adolescents.
    Fontenot HB; Fantasia HC
    Nurs Womens Health; 2015; 19(3):253-9. PubMed ID: 26058908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
    Varney SJ; Guest JF
    Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes toward long-acting reversible contraception among young women seeking abortion.
    Rose SB; Cooper AJ; Baker NK; Lawton B
    J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.